Hong Kong Stock Market Movers | Innovative Drug Concept Stocks Extend Gains; BofA Says Three Recent Major Collaborations Strengthen Sector Momentum, ESMO Expected to Bring Dense Catalysts

Zhitong Finance APP has learned that the rally in innovative drug concept stocks continues. As of press time, CanSino Biologics (06185.HK) rose 12.75% to HK$40.14; Ascletis Pharma-B (01672.HK) rose 9.39% to HK$8.915; Sino Biopharmaceutical (01177.HK) rose 4.77% to HK$5.815; Akeso (09926) rose 3.87% to HK$110.1.